United States Alteplase Market Report 2017

October 2017 | 99 pages | ID: UA504F57998WEN
QYResearch

Abstracts

In this report, the United States Alteplase market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Alteplase in these regions, from 2012 to 2022 (forecast).

United States Alteplase market competition by top manufacturers/players, with Alteplase sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Boehringer Ingelheim
• Kyowa Hakko Kirin
• Genentech
• Roche
• Tanabe Mitsubishi Pharma

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• 2 mg
• 50 mg
• 100 mg

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Alteplase for each application, including

• Hospital
• Clinic
• Pharmacy

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Alteplase Market Report 2017

1 ALTEPLASE OVERVIEW

1.1 Product Overview and Scope of Alteplase
1.2 Classification of Alteplase by Product Category
  1.2.1 United States Alteplase Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Alteplase Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 2 mg
  1.2.4 50 mg
  1.2.5 100 mg
1.3 United States Alteplase Market by Application/End Users
  1.3.1 United States Alteplase Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospital
  1.3.3 Clinic
  1.3.4 Pharmacy
1.4 United States Alteplase Market by Region
  1.4.1 United States Alteplase Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Alteplase Status and Prospect (2012-2022)
  1.4.3 Southwest Alteplase Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Alteplase Status and Prospect (2012-2022)
  1.4.5 New England Alteplase Status and Prospect (2012-2022)
  1.4.6 The South Alteplase Status and Prospect (2012-2022)
  1.4.7 The Midwest Alteplase Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Alteplase (2012-2022)
  1.5.1 United States Alteplase Sales and Growth Rate (2012-2022)
  1.5.2 United States Alteplase Revenue and Growth Rate (2012-2022)

2 UNITED STATES ALTEPLASE MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Alteplase Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Alteplase Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Alteplase Average Price by Players/Suppliers (2012-2017)
2.4 United States Alteplase Market Competitive Situation and Trends
  2.4.1 United States Alteplase Market Concentration Rate
  2.4.2 United States Alteplase Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Alteplase Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES ALTEPLASE SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Alteplase Sales and Market Share by Region (2012-2017)
3.2 United States Alteplase Revenue and Market Share by Region (2012-2017)
3.3 United States Alteplase Price by Region (2012-2017)

4 UNITED STATES ALTEPLASE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Alteplase Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Alteplase Revenue and Market Share by Type (2012-2017)
4.3 United States Alteplase Price by Type (2012-2017)
4.4 United States Alteplase Sales Growth Rate by Type (2012-2017)

5 UNITED STATES ALTEPLASE SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Alteplase Sales and Market Share by Application (2012-2017)
5.2 United States Alteplase Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES ALTEPLASE PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Boehringer Ingelheim
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Alteplase Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Boehringer Ingelheim Alteplase Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Kyowa Hakko Kirin
  6.2.2 Alteplase Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Kyowa Hakko Kirin Alteplase Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Genentech
  6.3.2 Alteplase Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Genentech Alteplase Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Roche
  6.4.2 Alteplase Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Roche Alteplase Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Tanabe Mitsubishi Pharma
  6.5.2 Alteplase Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Tanabe Mitsubishi Pharma Alteplase Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview

7 ALTEPLASE MANUFACTURING COST ANALYSIS

7.1 Alteplase Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Alteplase

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Alteplase Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Alteplase Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES ALTEPLASE MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Alteplase Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Alteplase Sales Volume Forecast by Type (2017-2022)
11.3 United States Alteplase Sales Volume Forecast by Application (2017-2022)
11.4 United States Alteplase Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Alteplase
Figure United States Alteplase Market Size (K Units) by Type (2012-2022)
Figure United States Alteplase Sales Volume Market Share by Type (Product Category) in 2016
Figure 2 mg Product Picture
Figure 50 mg Product Picture
Figure 100 mg Product Picture
Figure United States Alteplase Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Alteplase by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Pharmacy Examples
Table Key Downstream Customer in Pharmacy
Figure United States Alteplase Market Size (Million USD) by Region (2012-2022)
Figure The West Alteplase Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Alteplase Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Alteplase Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Alteplase Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Alteplase Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Alteplase Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Alteplase Sales (K Units) and Growth Rate (2012-2022)
Figure United States Alteplase Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Alteplase Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Alteplase Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Alteplase Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Alteplase Sales Share by Players/Suppliers
Figure 2017 United States Alteplase Sales Share by Players/Suppliers
Figure United States Alteplase Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Alteplase Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Alteplase Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Alteplase Revenue Share by Players/Suppliers
Figure 2017 United States Alteplase Revenue Share by Players/Suppliers
Table United States Market Alteplase Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Alteplase Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Alteplase Market Share of Top 3 Players/Suppliers
Figure United States Alteplase Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Alteplase Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Alteplase Product Category
Table United States Alteplase Sales (K Units) by Region (2012-2017)
Table United States Alteplase Sales Share by Region (2012-2017)
Figure United States Alteplase Sales Share by Region (2012-2017)
Figure United States Alteplase Sales Market Share by Region in 2016
Table United States Alteplase Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Alteplase Revenue Share by Region (2012-2017)
Figure United States Alteplase Revenue Market Share by Region (2012-2017)
Figure United States Alteplase Revenue Market Share by Region in 2016
Table United States Alteplase Price (USD/Unit) by Region (2012-2017)
Table United States Alteplase Sales (K Units) by Type (2012-2017)
Table United States Alteplase Sales Share by Type (2012-2017)
Figure United States Alteplase Sales Share by Type (2012-2017)
Figure United States Alteplase Sales Market Share by Type in 2016
Table United States Alteplase Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Alteplase Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Alteplase by Type (2012-2017)
Figure Revenue Market Share of Alteplase by Type in 2016
Table United States Alteplase Price (USD/Unit) by Types (2012-2017)
Figure United States Alteplase Sales Growth Rate by Type (2012-2017)
Table United States Alteplase Sales (K Units) by Application (2012-2017)
Table United States Alteplase Sales Market Share by Application (2012-2017)
Figure United States Alteplase Sales Market Share by Application (2012-2017)
Figure United States Alteplase Sales Market Share by Application in 2016
Table United States Alteplase Sales Growth Rate by Application (2012-2017)
Figure United States Alteplase Sales Growth Rate by Application (2012-2017)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Alteplase Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Boehringer Ingelheim Alteplase Sales Growth Rate (2012-2017)
Figure Boehringer Ingelheim Alteplase Sales Market Share in United States (2012-2017)
Figure Boehringer Ingelheim Alteplase Revenue Market Share in United States (2012-2017)
Table Kyowa Hakko Kirin Basic Information List
Table Kyowa Hakko Kirin Alteplase Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Kyowa Hakko Kirin Alteplase Sales Growth Rate (2012-2017)
Figure Kyowa Hakko Kirin Alteplase Sales Market Share in United States (2012-2017)
Figure Kyowa Hakko Kirin Alteplase Revenue Market Share in United States (2012-2017)
Table Genentech Basic Information List
Table Genentech Alteplase Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Genentech Alteplase Sales Growth Rate (2012-2017)
Figure Genentech Alteplase Sales Market Share in United States (2012-2017)
Figure Genentech Alteplase Revenue Market Share in United States (2012-2017)
Table Roche Basic Information List
Table Roche Alteplase Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Roche Alteplase Sales Growth Rate (2012-2017)
Figure Roche Alteplase Sales Market Share in United States (2012-2017)
Figure Roche Alteplase Revenue Market Share in United States (2012-2017)
Table Tanabe Mitsubishi Pharma Basic Information List
Table Tanabe Mitsubishi Pharma Alteplase Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Tanabe Mitsubishi Pharma Alteplase Sales Growth Rate (2012-2017)
Figure Tanabe Mitsubishi Pharma Alteplase Sales Market Share in United States (2012-2017)
Figure Tanabe Mitsubishi Pharma Alteplase Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Alteplase
Figure Manufacturing Process Analysis of Alteplase
Figure Alteplase Industrial Chain Analysis
Table Raw Materials Sources of Alteplase Major Players/Suppliers in 2016
Table Major Buyers of Alteplase
Table Distributors/Traders List
Figure United States Alteplase Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Alteplase Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Alteplase Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Alteplase Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Alteplase Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Alteplase Sales Volume (K Units) Forecast by Type in 2022
Table United States Alteplase Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Alteplase Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Alteplase Sales Volume (K Units) Forecast by Application in 2022
Table United States Alteplase Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Alteplase Sales Volume Share Forecast by Region (2017-2022)
Figure United States Alteplase Sales Volume Share Forecast by Region (2017-2022)
Figure United States Alteplase Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources